BIOTECH / BIOMEDICAL : I-Flow Corp. Gets U.S. Approval to Sell Self-Infusion Device
- Share via
I-Flow Corp. said Monday that it has received federal permission to market its first line of high-tech home infusion medical equipment.
Donald M. Earhart, the company’s chief executive officer, said the device is lightweight and computerized, enabling a patient to receive up to four infusions of drugs or nutrients either one at a time or simultaneously.
“This is the product we will finally go to market with,” said Earhart, adding that the potential market for the device is greater than $500 million a year in the United States.
Currently, he said, patients who need chemotherapy or other treatments with more than one drug or a combination of drugs and nutrients are using several single-channel pumps or cumbersome hospital systems. By contrast, Earhart said, patients can use the I-Flow equipment in their homes or take it with them to work or on a trip, carrying it in small bags.
Earhart said I-Flow is trying to raise additional funds from private investors to cover anticipated production costs.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
